Matthew J Schiewer

8PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 16, 2026
Development and validation of a digital pathology artificial intelligence (DPAI)-derived risk score predicting Gleason grade group reclassification for patients who are candidates for active surveillance.

|Jan 14, 2026
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.

Nicolas Gordon, Peter T Gallagher, Orly I Richter

|Sep 07, 2025
PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancer.

Moriah L Cunningham, Jasibel Vasquez-Gonzalez, Samantha M Barnada

|Apr 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles.

Candice L Bizzaro, Camila A Bach, Ricardo A Santos

|May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.

Sumaira Sardar, Christopher M McNair, Lakshmi Ravindranath

|Apr 18, 2024
PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer.

Moriah L Cunningham, Matthew J Schiewer

Pageof 2

Frequent Collaborators

2 joint publications

Ayesha A Shafi

2 joint publications

Moriah L Cunningham

2 joint publications

Wm Kevin Kelly

1 joint publications

Dale Muzzey